Login / Signup
Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations.
Inhye E Ahn
Xin Tian
Adrian Wiestner
Published in:
The New England journal of medicine (2020)
Keyphrases
</>
chronic lymphocytic leukemia